Do analysts prefer NXTT or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Next Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer VS or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Versus Systems 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is VS or SHPH more profitable?

Versus Systems' return on equity of -70.36% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Versus Systems N/A -70.36% -61.70% Shuttle Pharmaceuticals N/A -408.34% -138.15%

Do analysts recommend TAOP or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Taoping 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, TAOP or SHPH?

Taoping has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Taoping $30.82M 0.20 -$10.06M N/A N/A Shuttle Pharmaceuticals N/A N/A -$11.72M -$47.70 N/A

Is TAOP or SHPH more profitable?

Taoping's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Taoping N/A N/A N/A Shuttle Pharmaceuticals N/A -408.34% -138.15%

Do analysts rate AMST or SHPH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amesite 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SHPH or SVRE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shuttle Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SaverOne 2014 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, SHPH or SVRE?

SaverOne 2014 has higher revenue and earnings than Shuttle Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shuttle Pharmaceuticals N/A N/A -$11.72M -$47.70 N/A SaverOne 2014 $290K 22.42 -$8.55M N/A N/A

Is SHPH or SVRE more profitable?

SaverOne 2014's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Shuttle Pharmaceuticals N/A -408.34% -138.15% SaverOne 2014 N/A N/A N/A

Shuttle Pharmaceuticals (SHPH) Competitors

$3.55 -0.21 (-5.59%)

As of 01:55 PM Eastern

Compare

SHPH vs. NXTT, VS, TAOP, AMST, and SVRE

Should you buy Shuttle Pharmaceuticals stock or one of its competitors? Shuttle Pharmaceuticals's main competitors and comparable companies include Next Technology (NXTT), Versus Systems (VS), Taoping (TAOP), Amesite (AMST), and SaverOne 2014 (SVRE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Shuttle Pharmaceuticals compare to Next Technology?

Next Technology (NASDAQ:NXTT) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

2.7% of Next Technology shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 52.2% of Next Technology shares are held by insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Next Technology has a beta of 6, indicating that its share price is 500% more volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

Next Technology has higher revenue and earnings than Shuttle Pharmaceuticals. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than Next Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Next Technology	$11.61M	0.73	$143.16M	-$12.90 thousand	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

In the previous week, Shuttle Pharmaceuticals' average media sentiment score of 0.76 beat Next Technology's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Next Technology	Neutral
Shuttle Pharmaceuticals	Positive

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Next Technology's net margin of -2,355.97%. Next Technology's return on equity of -60.08% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Next Technology	-2,355.97%	-60.08%	-53.71%
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Next Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Next Technology beats Shuttle Pharmaceuticals on 7 of the 11 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Versus Systems?

Versus Systems (NASDAQ:VS) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

60.7% of Versus Systems shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 0.2% of Versus Systems shares are held by company insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Versus Systems has higher revenue and earnings than Shuttle Pharmaceuticals. Versus Systems is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Versus Systems	$2.18M	3.19	-$1.79M	-$0.35	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Versus Systems	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Versus Systems had 2 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 2 mentions for Versus Systems and 0 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 0.76 beat Versus Systems' score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Versus Systems	Neutral
Shuttle Pharmaceuticals	Positive

Versus Systems' return on equity of -70.36% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Versus Systems	N/A	-70.36%	-61.70%
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

Versus Systems has a beta of 1.36, indicating that its share price is 36% more volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

Summary

Versus Systems beats Shuttle Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Taoping?

Taoping (NASDAQ:TAOP) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Taoping	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Shuttle Pharmaceuticals' average media sentiment score of 0.76 beat Taoping's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Taoping	Neutral
Shuttle Pharmaceuticals	Positive

Taoping has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Taoping	$30.82M	0.20	-$10.06M	N/A	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

Taoping's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Taoping	N/A	N/A	N/A
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

Taoping has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market. Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

4.0% of Taoping shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 45.4% of Taoping shares are held by company insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Taoping beats Shuttle Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to Amesite?

Amesite (NASDAQ:AMST) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Amesite has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Shuttle Pharmaceuticals has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market.

3.6% of Amesite shares are owned by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. 36.5% of Amesite shares are owned by insiders. Comparatively, 0.4% of Shuttle Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Amesite's net margin of -873.02%. Amesite's return on equity of -154.31% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amesite	-873.02%	-154.31%	-129.67%
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amesite	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Amesite had 2 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 2 mentions for Amesite and 0 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 0.76 beat Amesite's score of 0.51 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Amesite	Positive
Shuttle Pharmaceuticals	Positive

Amesite has higher revenue and earnings than Shuttle Pharmaceuticals. Amesite is trading at a lower price-to-earnings ratio than Shuttle Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amesite	$110K	63.18	-$3.62M	-$0.63	N/A
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A

Summary

Amesite beats Shuttle Pharmaceuticals on 8 of the 12 factors compared between the two stocks.

How does Shuttle Pharmaceuticals compare to SaverOne 2014?

Shuttle Pharmaceuticals (NASDAQ:SHPH) and SaverOne 2014 (NASDAQ:SVRE) are both small-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

SaverOne 2014 has higher revenue and earnings than Shuttle Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shuttle Pharmaceuticals	N/A	N/A	-$11.72M	-$47.70	N/A
SaverOne 2014	$290K	22.42	-$8.55M	N/A	N/A

SaverOne 2014's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shuttle Pharmaceuticals	N/A	-408.34%	-138.15%
SaverOne 2014	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shuttle Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SaverOne 2014	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Shuttle Pharmaceuticals has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, SaverOne 2014 has a beta of 2.17, suggesting that its stock price is 117% more volatile than the broader market.

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.9% of SaverOne 2014 shares are owned by institutional investors. 0.4% of Shuttle Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Shuttle Pharmaceuticals' average media sentiment score of 0.76 beat SaverOne 2014's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Shuttle Pharmaceuticals	Positive
SaverOne 2014	Neutral

Summary

SaverOne 2014 beats Shuttle Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHPH vs. The Competition

Export

Metric	Shuttle Pharmaceuticals	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$2.27M	$15.93B	$30.82B	$13.08B
Dividend Yield	N/A	3.41%	2.75%	13.00%
P/E Ratio	-0.07	142.61	78.94	25.72
Price / Sales	N/A	1,285.29	589.84	85.59
Price / Cash	N/A	46.92	49.35	52.02
Price / Book	0.32	8.85	7.99	6.31
Net Income	-$11.72M	$433.53M	$702.33M	$359.73M
7 Day Performance	13.42%	1.68%	2.59%	1.56%
1 Month Performance	-5.59%	-1.42%	-1.62%	-3.48%
1 Year Performance	-91.89%	-0.34%	177.71%	5.68%

Shuttle Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHPH Shuttle Pharmaceuticals	1.3915 of 5 stars	$3.55 -5.6%	N/A	-91.4%	$2.27M	N/A	N/A	2
NXTT Next Technology	0.2729 of 5 stars	$5.29 +1.0%	N/A	-99.7%	$7.78M	$11.61M	N/A	8	News Coverage
VS Versus Systems	0.5287 of 5 stars	$1.10 -3.9%	N/A	-48.6%	$6.83M	$2.18M	N/A	8	News Coverage
TAOP Taoping	0.7709 of 5 stars	$0.70 -5.8%	N/A	-80.2%	$6.69M	$30.82M	N/A	80	Positive News
AMST Amesite	0.4686 of 5 stars	$1.02 +1.0%	N/A	-64.2%	$6.68M	$110K	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHPH) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. NXTT, VS, TAOP, AMST, and SVRE

How does Shuttle Pharmaceuticals compare to Next Technology?

Summary

How does Shuttle Pharmaceuticals compare to Versus Systems?

Summary

How does Shuttle Pharmaceuticals compare to Taoping?

Summary

How does Shuttle Pharmaceuticals compare to Amesite?

Summary

How does Shuttle Pharmaceuticals compare to SaverOne 2014?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shuttle Pharmaceuticals (SHPH) Competitors

SHPH vs. NXTT, VS, TAOP, AMST, and SVRE

How does Shuttle Pharmaceuticals compare to Next Technology?

Do institutionals and insiders hold more shares of NXTT or SHPH?

Which has more risk and volatility, NXTT or SHPH?

Which has stronger earnings & valuation, NXTT or SHPH?

Does the media favor NXTT or SHPH?

Is NXTT or SHPH more profitable?

Do analysts prefer NXTT or SHPH?

Summary

How does Shuttle Pharmaceuticals compare to Versus Systems?

Do insiders and institutionals believe in VS or SHPH?

Which has preferable earnings & valuation, VS or SHPH?

Do analysts prefer VS or SHPH?

Does the media prefer VS or SHPH?

Is VS or SHPH more profitable?

Which has more risk and volatility, VS or SHPH?

Summary

How does Shuttle Pharmaceuticals compare to Taoping?

Do analysts recommend TAOP or SHPH?

Does the media favor TAOP or SHPH?

Which has higher valuation & earnings, TAOP or SHPH?

Is TAOP or SHPH more profitable?

Which has more volatility and risk, TAOP or SHPH?

Do insiders & institutionals have more ownership in TAOP or SHPH?

Summary

How does Shuttle Pharmaceuticals compare to Amesite?

Which has more risk & volatility, AMST or SHPH?

Do insiders & institutionals hold more shares of AMST or SHPH?

Is AMST or SHPH more profitable?

Do analysts rate AMST or SHPH?

Does the media refer more to AMST or SHPH?

Which has higher earnings & valuation, AMST or SHPH?

Summary

How does Shuttle Pharmaceuticals compare to SaverOne 2014?

Which has preferable earnings & valuation, SHPH or SVRE?

Is SHPH or SVRE more profitable?

Do analysts rate SHPH or SVRE?

Which has more volatility & risk, SHPH or SVRE?

Do institutionals and insiders have more ownership in SHPH or SVRE?

Does the media prefer SHPH or SVRE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHPH vs. The Competition

Shuttle Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools